Market Research

North America Cat Vaccine Market Size, Share & Trends Analysis Report By Component, By Route of Administration (Injectables, Intranasal, and Oral), By Duration of Immunity, By Disease Type, By Type, By Country and Growth Forecast, 2024 - 2031

Best Price Guarantee Length Publisher Published Date SKU
from $1,500 120 Pages Knowledge Based Value (KBV) Research July, 2024 KBV19028703
Best Price Guarantee
Price from $1,500
Length 120 Pages
Publisher Knowledge Based Value (KBV) Research
Published Date July, 2024
SKU KBV19028703

North America Cat Vaccine Market Size, Share & Trends Analysis Report By Component, By Route of Administration (Injectables, Intranasal, and Oral), By Duration of Immunity, By Disease Type, By Type, By Country and Growth Forecast, 2024 - 2031


The North America Cat Vaccine Market would witness market growth of 8.7% CAGR during the forecast period (2024-2031).

The US market dominated the North America Cat Vaccine Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $637.8 million by 2031. The Canada market is experiencing a CAGR of 11% during (2024 - 2031). Additionally, The Mexico market would exhibit a CAGR of 10.1% during (2024 - 2031).

The market has been experiencing significant growth, driven by many factors ranging from increasing pet ownership to advancements in veterinary medicine. As the understanding of feline health continues to expand, the importance of vaccinations in safeguarding the well-being of cats has become increasingly evident. The increasing number of households adopting cats as pets is one of the most significant factors driving the growth of the market. People are increasingly recognizing the companionship and emotional benefits pets, particularly cats, can provide. Vaccinations are essential for preventing various infectious diseases affecting cats, ensuring they lead healthy and fulfilling lives.

Greater awareness about the importance of pet vaccinations has been a driving force in encouraging more pet owners to vaccinate their cats. This heightened awareness is primarily attributable to the initiatives of veterinary organizations and pet health campaigns, which underscore the critical role of vaccinations in the prevention of diseases. These initiatives have successfully educated pet owners about the benefits of vaccinations, leading to higher vaccination rates and healthier pets.

In Mexico, the demand for cat vaccines is increasing due to heightened public health concerns and growing pet ownership. The National Institute of Statistics and Geography (INEGI) reported that pet ownership, including cats, has increased in urban areas. Public health initiatives aimed at controlling rabies, such as the annual National Vaccination Week, have been crucial in promoting the importance of pet vaccinations. These campaigns, supported by the Ministry of Health, provide free or low-cost rabies vaccinations for pets, significantly boosting vaccination rates. Hence, rising pet ownership, increasing awareness of pet health, and a focus on preventative care are expected to continue driving the regional market forward.

Based on Component, the market is segmented into Combined Vaccines, and Mono Vaccines. Based on Route of Administration, the market is segmented into Injectables, Intranasal, and Oral. Based on Duration of Immunity, the market is segmented into 1 Year, 3 Year, and Others. Based on Disease Type, the market is segmented into Feline Respiratory Diseases, Feline Rabies, Feline Panleukopenia (Feline Distemper), Feline Leukemia, and Others. Based on Type, the market is segmented into Modified/Attenuated Live, Inactivated (Killed), and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

List of Key Companies Profiled
  • Zoetis, Inc.
  • Elanco Animal Health, Inc.
  • Merck & Co., Inc.
  • Boehringer Ingelheim International GmbH
  • Covetrus, Inc. (Clayton, Dubilier & Rice, LLC)
  • Virbac
  • Heska Corporation (Antech Diagnostics, Inc)
  • Ceva Sante Animale
  • Bioveta, a.s.
North America Cat Vaccine Market Report Segmentation

By Component
  • Combined Vaccines
  • Mono Vaccines
By Route of Administration
  • Injectables
  • Intranasal
  • Oral
By Duration of Immunity
  • 1 Year
  • 3 Year
  • Others
By Disease Type
  • Feline Respiratory Diseases
  • Feline Rabies
  • Feline Panleukopenia (Feline Distemper)
  • Feline Leukemia
  • Others
By Type
  • Modified/Attenuated Live
  • Inactivated (Killed)
  • Others
By Country
  • US
  • Canada
  • Mexico
  • Rest of North America


Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Cat Vaccine Market, by Component
1.4.2 North America Cat Vaccine Market, by Route of Administration
1.4.3 North America Cat Vaccine Market, by Duration of Immunity
1.4.4 North America Cat Vaccine Market, by Disease Type
1.4.5 North America Cat Vaccine Market, by Type
1.4.6 North America Cat Vaccine Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter Five Forces Analysis
Chapter 4. Strategies Deployed in Cat Vaccine Market
Chapter 5. North America Cat Vaccine Market by Component
5.1 North America Combined Vaccines Market by Region
5.2 North America Mono Vaccines Market by Region
Chapter 6. North America Cat Vaccine Market by Route of Administration
6.1 North America Injectables Market by Country
6.2 North America Intranasal Market by Country
6.3 North America Oral Market by Country
Chapter 7. North America Cat Vaccine Market by Duration of Immunity
7.1 North America 1 Year Market by Country
7.2 North America 3 Year Market by Country
7.3 North America Others Market by Country
Chapter 8. North America Cat Vaccine Market by Disease Type
8.1 North America Feline Respiratory Diseases Market by Country
8.2 North America Feline Rabies Market by Country
8.3 North America Feline Panleukopenia (Feline Distemper) Market by Country
8.4 North America Feline Leukemia Market by Country
8.5 North America Others Market by Country
Chapter 9. North America Cat Vaccine Market by Type
9.1 North America Modified/Attenuated Live Market by Country
9.2 North America Inactivated (Killed) Market by Country
9.3 North America Others Market by Country
Chapter 10. North America Cat Vaccine Market by Country
10.1 US Cat Vaccine Market
10.1.1 US Cat Vaccine Market by Component
10.1.2 US Cat Vaccine Market by Route of Administration
10.1.3 US Cat Vaccine Market by Duration of Immunity
10.1.4 US Cat Vaccine Market by Disease Type
10.1.5 US Cat Vaccine Market by Type
10.2 Canada Cat Vaccine Market
10.2.1 Canada Cat Vaccine Market by Component
10.2.2 Canada Cat Vaccine Market by Route of Administration
10.2.3 Canada Cat Vaccine Market by Duration of Immunity
10.2.4 Canada Cat Vaccine Market by Disease Type
10.2.5 Canada Cat Vaccine Market by Type
10.3 Mexico Cat Vaccine Market
10.3.1 Mexico Cat Vaccine Market by Component
10.3.2 Mexico Cat Vaccine Market by Route of Administration
10.3.3 Mexico Cat Vaccine Market by Duration of Immunity
10.3.4 Mexico Cat Vaccine Market by Disease Type
10.3.5 Mexico Cat Vaccine Market by Type
10.4 Rest of North America Cat Vaccine Market
10.4.1 Rest of North America Cat Vaccine Market by Component
10.4.2 Rest of North America Cat Vaccine Market by Route of Administration
10.4.3 Rest of North America Cat Vaccine Market by Duration of Immunity
10.4.4 Rest of North America Cat Vaccine Market by Disease Type
10.4.5 Rest of North America Cat Vaccine Market by Type
Chapter 11. Company Profiles
11.1 Zoetis, Inc.
11.1.1 Company Overview
11.1.2 Financial Analysis
11.1.3 Regional Analysis
11.1.4 Research & Development Expenses
11.1.5 Recent strategies and developments:
11.1.5.1 Partnerships, Collaborations, and Agreements:
11.1.5.2 Product Launches and Product Expansions:
11.1.5.3 Acquisition and Mergers:
11.1.6 SWOT Analysis
11.2 Elanco Animal Health, Inc.
11.2.1 Company Overview
11.2.2 Financial Analysis
11.2.3 Regional Analysis
11.2.4 Research & Development Expenses
11.2.5 SWOT Analysis
11.3 Merck & Co., Inc.
11.3.1 Company Overview
11.3.2 Financial Analysis
11.3.3 Segmental and Regional Analysis
11.3.4 Research & Development Expenses
11.3.5 SWOT Analysis
11.4 Boehringer Ingelheim International GmbH
11.4.1 Company Overview
11.4.2 Financial Analysis
11.4.3 Regional & Segmental Analysis
11.4.4 Research & Development Expenses
11.4.5 Recent strategies and developments:
11.4.5.1 Trials and Approvals:
11.4.6 SWOT Analysis
11.5 Covetrus, Inc. (Clayton, Dubilier & Rice, LLC)
11.5.1 Company Overview
11.5.2 SWOT Analysis
11.6 Virbac
11.6.1 Company Overview
11.6.2 Financial Analysis
11.6.3 Regional Analysis
11.6.4 Recent strategies and developments:
11.6.4.1 Acquisition and Mergers:
11.6.5 SWOT Analysis
11.7 Heska Corporation (Antech Diagnostics, Inc)
11.7.1 Company Overview
11.7.2 SWOT Analysis
11.8 Ceva Sante Animale
11.8.1 Company Overview
11.8.2 SWOT Analysis
11.9 Bioveta, a.s.
11.9.1 Company Overview

$1,500
$1,800
$2,520

Research Assistance

US: 800.298.5699
Int'l: +1.240.747.3093
Live help
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks

Cookie Settings